Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Kawasaki syndrome.

Jane C Burns1, Mary P Glodé

  • 1Division of Allergy, Immunology, and Rheumatology, Department of Pediatrics, University of California San Diego School of Medicine, La Jolla, CA, USA. jcburns@ucsd.edu

Lancet (London, England)
|August 11, 2004
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Characterization of innate immune cells with regulatory functions in subjects with a remote history of Kawasaki disease who lack natural regulatory T cell specificities.

Immunology letters·2026
Same author

Acute Intensification May Reduce Persistent Coronary Artery Damage from Kawasaki Disease in Infants Younger Than 6 Months.

The Journal of pediatrics·2026
Same author

Glucocorticoids in Kawasaki Disease - Refining Indications and the Science.

The New England journal of medicine·2026
Same author

Kawasaki Disease in Adults: A Call to Action to Manage Lifelong Coronary Risk.

Journal of the American College of Cardiology·2026
Same author

Minimal correlation but complementary diagnostic utility for plasma cell-free RNA and proteins.

Communications medicine·2026
Same author

Kawasaki Disease and the Importance of Family History.

JACC. Case reports·2026
Same journal

Rethinking anticoagulation intensity during extracorporeal membrane oxygenation.

Lancet (London, England)·2026
Same journal

Standard-dose unfractionated heparin versus low-dose unfractionated heparin and low-molecular-weight heparin in extracorporeal life support (RATE): an open-label, randomised, non-inferiority trial.

Lancet (London, England)·2026
Same journal

Inherited retinal degenerations: clinical phenotypes and emerging therapies.

Lancet (London, England)·2026
Same journal

Documenting hospice care.

Lancet (London, England)·2026
Same journal

After the wood chipper.

Lancet (London, England)·2026
Same journal

Assisted dying and the silencing of medicine's next generation.

Lancet (London, England)·2026
See all related articles

Kawasaki syndrome is a challenging childhood vasculitis. Early treatment is crucial to prevent serious cardiovascular damage, despite diagnostic difficulties.

Area of Science:

  • Pediatric Rheumatology
  • Cardiovascular Pathology

Background:

  • Kawasaki syndrome is an acute, self-limited vasculitis affecting children.
  • It presents diagnostic challenges due to lack of specific tests.
  • Delayed treatment carries a significant risk of cardiovascular sequelae.

Purpose of the Study:

  • To provide a comprehensive review of Kawasaki syndrome.
  • To discuss diagnostic challenges, epidemiology, and aetiology.
  • To cover pathology, immunopathogenesis, therapy, and long-term outcomes.

Main Methods:

  • Literature review encompassing history, diagnosis, epidemiology, aetiology, pathology, immunopathogenesis, therapy, and genetic influences.
  • Discussion of long-term cardiovascular sequelae.

Related Experiment Videos

Main Results:

  • Kawasaki syndrome requires early recognition and treatment.
  • Effective therapy exists, but diagnosis can be difficult.
  • A 25% risk of cardiovascular damage exists without timely intervention.

Conclusions:

  • Kawasaki syndrome is a critical pediatric condition requiring prompt management.
  • Understanding its multifaceted aspects is key to improving patient outcomes.
  • Further research into genetic influences and long-term sequelae is warranted.